Michael A. Sherman - Net Worth and Insider Trading
Michael A. Sherman Net Worth
The estimated net worth of Michael A. Sherman is at least $9 Million dollars as of 2023-11-28. Michael A. Sherman is the President and CEO of Endocyte Inc and owns about 367,837 shares of Endocyte Inc (ECYT) stock worth over $9 Million. Michael A. Sherman is also the CEO of Chimerix Inc and owns about 423,408 shares of Chimerix Inc (CMRX) stock worth over $411,764. Details can be seen in Michael A. Sherman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael A. Sherman has not made any transactions after 2023-05-12 and currently still holds the listed stock(s).
Transaction Summary of Michael A. Sherman
Michael A. Sherman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael A. Sherman owns 5 companies in total, including BioSpecifics Technologies Corp () , Chimerix Inc () , and Endocyte Inc () among others .
Insider Ownership Summary of Michael A. Sherman
|Ticker||Comapny||Transaction Date||Type of Owner|
|BioSpecifics Technologies Corp||2020-05-01||director|
|Chimerix Inc||2023-05-12||director & Chief Executive Officer|
|Endocyte Inc||2018-12-21||director & President and CEO|
|Mead Johnson Nutrition Co||2017-06-15||director|
|Werewolf Therapeutics Inc||2022-06-01||director|
Michael A. Sherman Latest Holdings Summary
Michael A. Sherman currently owns a total of 2 stocks. Among these stocks, Michael A. Sherman owns 367,837 shares of Endocyte Inc (ECYT) as of October 5, 2018, with a value of $9 Million and a weighting of 95.54000000000001%. Michael A. Sherman also owns 423,408 shares of Chimerix Inc (CMRX) as of May 12, 2023, with a value of $411,764 and a weighting of 4.46%.
Michael A. Sherman Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael A. Sherman has made a total of 0 transactions in Endocyte Inc (ECYT) over the past 5 years. The most-recent trade in Endocyte Inc is the sale of 28,146 shares on October 5, 2018, which brought Michael A. Sherman around $437,670.
According to the SEC Form 4 filings, Michael A. Sherman has made a total of 3 transactions in Chimerix Inc (CMRX) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Chimerix Inc is the acquisition of 87,000 shares on May 12, 2023, which cost Michael A. Sherman around $97,440.
Insider Trading History of Michael A. Sherman
Michael A. Sherman Trading Performance
GuruFocus tracks the stock performance after each of Michael A. Sherman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael A. Sherman is 22.07%. GuruFocus also compares Michael A. Sherman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael A. Sherman within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael A. Sherman's insider trading performs compared to the benchmark.
Performance of Michael A. Sherman
|1 Month||3 Months||6 Months||1 Year||2 Years||3 Years|
|Relative Return to S&P 500(%)||2.9||11.09||-13.31||550.42||47.85||-19.97|
Michael A. Sherman Ownership Network
Ownership Network List of Michael A. Sherman
Ownership Network Relation of Michael A. Sherman
Michael A. Sherman Owned Company Details
What does BioSpecifics Technologies Corp do?
Who are the key executives at BioSpecifics Technologies Corp?
Michael A. Sherman is the director of BioSpecifics Technologies Corp. Other key executives at BioSpecifics Technologies Corp include director & 10 percent owner Toby Wegman , director & Chief Executive Officer Joseph Truitt , and Chief Financial Officer Patrick Hutchison .
BioSpecifics Technologies Corp () Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of BioSpecifics Technologies Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioSpecifics Technologies Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
BioSpecifics Technologies Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.
BioSpecifics Technologies Corp Insider Transactions
Michael A. Sherman Mailing Address
Above is the net worth, insider trading, and ownership report for Michael A. Sherman. You might contact Michael A. Sherman via mailing address: 3000 Kent Ave Ste A1-100, West Lafayette In 47906.